Back to Screener

Chiron Real Estate Inc. Common Stock (XRN)

NYSE Small Cap
$37.42
Market Cap: $495M
Data as of Mar 31, 2026 (TTM)

Price History

Feb 26, 2026 — May 24, 2026

Investment Snapshot

  • P/B of 0.99 — trading below book value
  • Piotroski F-Score 5/9 — moderate financial health
  • Loss-making — negative ROE of -1.1%
  • Revenue growing at 7% annually

Chiron Real Estate Inc. Common Stock (XRN) is a publicly traded company, listed on the NYSE , with a market capitalisation of $495 million . Key value metrics: P/B ratio 0.99, Piotroski F-Score 5 out of 9 (moderate financial health) .

Value Score

72
out of 100
Try PRO Free — See Full Breakdown

Key Metrics

P/E Ratio
—
P/B Ratio
0.99
EPS
$-0.41
Div. Yield
3.5%
PEG Ratio
—
P/S Ratio
—
EV/EBITDA
—
ROE
—
ROA
—
Gross Margin
—
Op. Margin
—
Net Margin
—
Debt/Equity
—
Current Ratio
—
Unlock 19 More Metrics — 7 Days Free
Data sourced from SEC EDGAR and Polygon.io. Methodology.

Chiron Real Estate Inc. Common Stock — Fundamental Analysis Summary

On financial health, XRN shows a moderate Piotroski F-Score of 5/9, and negative return on equity of -1.1%, and minimal leverage with a debt-to-equity ratio of 0.00.

StockPik's composite Value Score for XRN is 72/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

XRN shows revenue growing at 7% year-over-year, with earnings declining at 1,594%.

XRN pays a solid dividend yield of 3.5%.

Stocks below book value
Other stocks trading at a discount to net assets (P/B < 1)
High-yield dividend stocks
Other stocks paying a dividend yield of 3% or more
How is the Value Score calculated?
Read our full methodology →
What is the Piotroski F-Score?
The 9-point financial health score explained, with worked examples →
Previous
XRAY
Next
XRX